Business Context and Reporting Period
Company: Principal Financial Group, Inc.
Filing Type: Form 8-K (Current Report)
Date: September 30, 2010
Event: Announcement of a strategic decision to exit the medical insurance business (insured and self-insured) within the next 36 months.
Key Financial Metrics and Impact
The filing does not provide full period revenue, profit, or cash flow statements. However, it quantifies the specific financial impact of the strategic exit:
- EPS Impact (Q3 2010): Estimated negative impact of $0.03 to $0.04 per share on operating earnings.
- EPS Impact (Full Year 2010): Estimated negative impact of $0.18 to $0.20 per share on operating earnings.
- Capital Release: Expected release of $100 million to $120 million in capital over the 36-month transition period.
- Assets Under Management: $284.7 billion (as of June 30, 2010).
- Customer Base: Approximately 18.9 million customers worldwide.
Material Changes and Strategic Shift
The primary material change is the divestiture of the medical insurance segment. Management cites the following reasons:
- Relative Decline: The medical business has been declining in relative size due to strong growth in retirement and asset management segments.
- Capital Allocation: The decision allows the company to focus capital and resources on asset accumulation and asset management opportunities domestically and internationally.
- Market Dynamics: The medical insurance sector undergoes rapid change, requiring additional capital investment to remain competitive, which management deems inefficient for the company's current strategy.
- Transition Agreement: An agreement has been reached with UnitedHealthcare to renew coverage for existing customers during the 36-month transition.
Outlook, Risks, and Unusual Items
Operational Impact:
- Workforce: Approximately 1,500 employees are in the medical insurance area. Initially, about 150 positions will be impacted as functions cease. The company intends to place qualified employees in other open positions where possible.
- Timeline: Sales will cease immediately, with the renewal process and full transition to be completed within 36 months.
- Forward-Looking Statements: Actual results may differ materially from anticipated results due to assumptions regarding future conditions.
- Market Risks: Adverse capital and credit market conditions, volatility in financial markets, and changes in interest rates.
- Regulatory Risks: Changes in laws, regulations, or accounting standards that may reduce profitability.
- Liquidity Risks: Reliance on dividends from subsidiaries to meet debt obligations and potential requirements to post collateral.
The exit of the medical business is a significant structural change that will alter the company's risk profile and diversification, though management notes it supports growth in risk businesses for small- and medium-sized enterprises.
Investor Verification Checklist
- Verify the specific timeline and regulatory approvals required for the 36-month transition to UnitedHealthcare.
- Confirm the final number of employee positions eliminated versus redeployed during the transition.
- Monitor the actual capital release against the estimated $100 million to $120 million range over the next three years.
- Review subsequent quarterly reports to assess the impact on operating earnings once the medical business is fully excluded.
- Assess the impact of the reduced diversification benefit on the company's overall risk rating and cost of capital.